Michael John Tomsicek

Insider Reports History

Entity
Individual
Location
28 Overlook Drive, Bedford, MA
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael John Tomsicek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 1.89K $118K $62.50 Aug 6, 2021 Direct
CRISPR Therapeutics AG Chief Financial Officer Stock Option (Right to Buy) 131K Mar 11, 2021 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40K Aug 28, 2024 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20.3K Jun 20, 2024 Direct

Insider Reports Filed by Michael John Tomsicek

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIST Milestone Pharmaceuticals Inc. Aug 28, 2024 1 $0 4 Aug 29, 2024 Director
ACRV Acrivon Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Director
MIST Milestone Pharmaceuticals Inc. Oct 19, 2022 1 $79.8K 4 Oct 21, 2022 Director
MIST Milestone Pharmaceuticals Inc. Jul 5, 2022 1 $0 4 Aug 11, 2022 Director
CRSP CRISPR Therapeutics AG Aug 6, 2021 4 -$3.02M 4 Aug 10, 2021 Chief Financial Officer
MIST Milestone Pharmaceuticals Inc. Jun 14, 2021 1 $0 4 Jul 29, 2021 Director